Vivos Therapeutics gets FDA clearance for sleep apnea treatment device

Medical technology company Vivos Therapeutics received FDA 510(k) clearance for its daytime-nighttime device to treat obstructive sleep apnea.

Advertisement

Vivos Therapeutics develops treatments for dentofacial abnormalities, mild-to-moderate obstructive sleep apnea and snoring in adults.

The device expands the palate to open the airway and facilitate nasal breathing, according to a Jan. 4 news release. It is Vivos’ longest standing appliance and is used most among its trained dentists. The device can also be used in conjunction with other treatment modalities.

At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.

Register to Attend Webinar

The Multi-Location A/R Framework: Grow Revenue, Not Your Back Office

Wednesday, July 29
12:00 PM - 1:00 PM CDT

Presenters: Pam Draper, Partnerships for DentistsSamantha Champagnie, Revenue Cycle Management, Imagen Dental PartnersAphton McElheney, Pearly

Advertisement

Next Up in Dental Technology

Advertisement

Comments are closed.